Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2980)
All Articles published online
|
Apr 7, 2008 (publication date) through Jun 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu LY, Han YC, Wu SH, Lv ZH. Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer. World J Gastroenterol 2008; 14(13): 2110-2114 [PMID: 18395916 DOI: 10.3748/wjg.14.2110] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i13/2110.htm |
| Number | Citing Articles |
| 1 |
Anette M. Høye, Janine T. Erler. Structural ECM components in the premetastatic and metastatic niche. American Journal of Physiology-Cell Physiology 2016; 310(11): C955 doi: 10.1152/ajpcell.00326.2015
|
| 2 |
Ana Margarida Moreira, Joana Pereira, Soraia Melo, Maria Sofia Fernandes, Patrícia Carneiro, Raquel Seruca, Joana Figueiredo. The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression. Cells 2020; 9(2): 394 doi: 10.3390/cells9020394
|
| 3 |
Lei Cui, Qing Zhang, Zhengfa Mao, Jixiang Chen, Xuqing Wang, Jianguo Qu, Jianxin Zhang, Dayong Jin. CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells. Tumor Biology 2011; 32(4): 721 doi: 10.1007/s13277-011-0173-6
|
| 4 |
Dong Yin, Weikai Chen, James O'Kelly, Daning Lu, Michelle Ham, Ngan B. Doan, Dong Xie, Charles Wang, Jay Vadgama, Jonathan W. Said, Keith L. Black, H. Phillip Koeffler. Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme. International Journal of Cancer 2010; 127(10): 2257 doi: 10.1002/ijc.25257
|
| 5 |
Ryoko Kikuchi, Yoshihiro Kikuchi, Hitoshi Tsuda, Hitoshi Maekawa, Ken-ichi Kozaki, Issei Imoto, Seiichi Tamai, Akihiro Shiotani, Keiichi Iwaya, Masaru Sakamoto, Takao Sekiya, Osamu Matsubara. The expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancer. Human Cell 2014; 27(3): 121 doi: 10.1007/s13577-014-0092-0
|
| 6 |
Jun Li, Xiangyu Gao, Ke Ji, Andrew J. Sanders, Zhongtao Zhang, Wen G. Jiang, Jiafu Ji, Lin Ye. Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression. Oncology Reports 2016; 36(5): 2517 doi: 10.3892/or.2016.5074
|
| 7 |
Yiting Qiao, Tongyu Li, Shusen Zheng, Hangxiang Wang. The Hippo pathway as a drug target in gastric cancer. Cancer Letters 2018; 420: 14 doi: 10.1016/j.canlet.2018.01.062
|
| 8 |
Farideh Kamarehei, Massoud Saidijam, Amir Taherkhani. Prognostic biomarkers and molecular pathways mediating Helicobacter pylori–induced gastric cancer: a network-biology approach. Genomics & Informatics 2023; 21(1): e8 doi: 10.5808/gi.22072
|
| 9 |
Ildikó Klemmer, Shintaro Yagi, Olav A. Gressner. Oral application of 1,7‐dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis. Hepatology Research 2011; 41(11): 1094 doi: 10.1111/j.1872-034X.2011.00856.x
|
| 10 |
Xue-Ting Li, Jia-Yu Li, Guang-Chun Zeng, Li Lu, Michael J. Jarrett, Ye Zhao, Qing-Zhou Yao, Xiuwei Chen, Kai-Jiang Yu. Overexpression of connective tissue growth factor is associated with tumor progression and unfavorable prognosis in endometrial cancer. Cancer Biomarkers 2019; 25(4): 295 doi: 10.3233/CBM-190099
|
| 11 |
Adele Vivacqua, Enrica Romeo, Paola De Marco, Ernestina Marianna De Francesco, Sergio Abonante, Marcello Maggiolini. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells. Breast Cancer Research and Treatment 2012; 133(3): 1025 doi: 10.1007/s10549-011-1901-8
|
| 12 |
Maria Francesca Santolla, Rosamaria Lappano, Francesca Cirillo, Damiano Cosimo Rigiracciolo, Anna Sebastiani, Sergio Abonante, Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Teresa Di Martino, Marcello Maggiolini, Adele Vivacqua. miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0767-6
|
| 13 |
Dongning Liu, Lei Zhang, Zhiyong Shen, Fei Tan, Yanfeng Hu, Jiang Yu, Guoxin Li. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer. Gastric Cancer 2013; 16(4): 498 doi: 10.1007/s10120-013-0232-3
|
| 14 |
Zihao Chen, Ning Zhang, Hang Yin Chu, Yuanyuan Yu, Zong-Kang Zhang, Ge Zhang, Bao-Ting Zhang. Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.593269
|
| 15 |
Weijian Lun, Xiongjian Wu, Qiliang Deng, Fachao Zhi. MiR-218 regulates epithelial–mesenchymal transition and angiogenesis in colorectal cancer via targeting CTGF. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0575-2
|
| 16 |
Deo Prakash Pandey, Rosamaria Lappano, Lidia Albanito, Antonio Madeo, Marcello Maggiolini, Didier Picard. Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. The EMBO Journal 2009; 28(5): 523 doi: 10.1038/emboj.2008.304
|
| 17 |
Haijun Zhang, Fanyan Meng, Gang Liu, Bin Zhang, Jun Zhu, Feng Wu, Stephen P. Ethier, Fred Miller, Guojun Wu. Forkhead Transcription Factor Foxq1 Promotes Epithelial–Mesenchymal Transition and Breast Cancer Metastasis. Cancer Research 2011; 71(4): 1292 doi: 10.1158/0008-5472.CAN-10-2825
|
| 18 |
Patricia Garcia, Pamela Leal, Carmen Ili, Priscilla Brebi, Hector Alvarez, Juan C. Roa. Inhibition of connective tissue growth factor (CTGF/CCN2) in gallbladder cancer cells leads to decreased growth in vitro. International Journal of Experimental Pathology 2013; 94(3): 195 doi: 10.1111/iep.12023
|
| 19 |
Growth Factors and Their Receptors in Cell Differentiation, Cancer and Cancer Therapy. 2011; : 249 doi: 10.1016/B978-0-12-387819-9.00029-3
|
| 20 |
Peng Zhang, Fang‐Zhou Chen, Qing‐Bin Jia, Dian‐Feng Hu. Upregulation of microRNA‐133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway. IUBMB Life 2019; 71(12): 1857 doi: 10.1002/iub.2126
|
| 21 |
Olav A. Gressner, Chunfang Gao, Katharina Rehbein, Birgit Lahme, Monika Siluschek, Thomas Berg, Tobias Müller, Axel M. Gressner. Elevated concentrations of 15‐deoxy‐Δ12,14‐prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor γ‐inducing drugs. Liver International 2009; 29(5): 730 doi: 10.1111/j.1478-3231.2008.01895.x
|
| 22 |
Wei Kang, Tingting Huang, Yuhang Zhou, Jinglin Zhang, Raymond W. M. Lung, Joanna H. M. Tong, Anthony W. H. Chan, Bin Zhang, Chi Chun Wong, Feng Wu, Yujuan Dong, Shiyan Wang, Weiqin Yang, Yi Pan, Wing Po Chak, Alvin H. K. Cheung, Jesse C. S. Pang, Jun Yu, Alfred S. L. Cheng, Ka Fai To. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0134-0
|
| 23 |
Leili Rejali, Ehsan Nazemalhosseini-Mojarad, Laura Valle, Mazaher Maghsoudloo, Hamid Asadzadeh Aghdaei, Hadis Mohammadpoor, Mohammad Reza Zali, Binazir Khanabadi, Maliheh Entezari, Kiavash Hushmandi, Afshin Taheriazam, Mehrdad Hashemi. Identification of antisense and sense RNAs of intracrine fibroblast growth factor components as novel biomarkers in colorectal cancer and in silico studies for drug and nanodrug repurposing. Environmental Research 2023; 239: 117117 doi: 10.1016/j.envres.2023.117117
|
| 24 |
Patricia Garcia, Pamela Leal, Hector Alvarez, Priscilla Brebi, Carmen Ili, Oscar Tapia, Juan C. Roa. Connective Tissue Growth Factor Immunohistochemical Expression Is Associated With Gallbladder Cancer Progression. Archives of Pathology & Laboratory Medicine 2013; 137(2): 245 doi: 10.5858/arpa.2011-0628-OA
|
| 25 |
Jing Cao, Jiao Gong, Xinhua Li, Zhaoxia Hu, Yingjun Xu, Hong Shi, Danyang Li, Guangjian Liu, Yusheng Jie, Bo Hu, Yutian Chong. Unsupervised Hierarchical Clustering Identifies Immune Gene Subtypes in Gastric Cancer. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.692454
|
| 26 |
Inge Ubink, Elisha R. Verhaar, Onno Kranenburg, Roel Goldschmeding. A potential role for CCN2/CTGF in aggressive colorectal cancer. Journal of Cell Communication and Signaling 2016; 10(3): 223 doi: 10.1007/s12079-016-0347-5
|
| 27 |
Dat T. Vo, Dharmalingam Subramaniam, Marc Remke, Tarea L. Burton, Philip J. Uren, Jonathan A. Gelfond, Raquel de Sousa Abreu, Suzanne C. Burns, Mei Qiao, Uthra Suresh, Andrey Korshunov, Adrian M. Dubuc, Paul A. Northcott, Andrew D. Smith, Stefan M. Pfister, Michael D. Taylor, Sarath C. Janga, Shrikant Anant, Christine Vogel, Luiz O.F. Penalva. The RNA-Binding Protein Musashi1 Affects Medulloblastoma Growth via a Network of Cancer-Related Genes and Is an Indicator of Poor Prognosis. The American Journal of Pathology 2012; 181(5): 1762 doi: 10.1016/j.ajpath.2012.07.031
|
| 28 |
Rosamaria Lappano, Camillo Rosano, Paola De Marco, Ernestina Marianna De Francesco, Vincenzo Pezzi, Marcello Maggiolini. Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Molecular and Cellular Endocrinology 2010; 320(1-2): 162 doi: 10.1016/j.mce.2010.02.006
|
| 29 |
Zi-Ning Lei, Qiu-Xu Teng, Qin Tian, Wei Chen, Yuhao Xie, Kaiming Wu, Qianlin Zeng, Leli Zeng, Yihang Pan, Zhe-Sheng Chen, Yulong He. Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01190-w
|
| 30 |
Antonio Madeo, Marcello Maggiolini. Nuclear Alternate Estrogen Receptor GPR30 Mediates 17β-Estradiol–Induced Gene Expression and Migration in Breast Cancer–Associated Fibroblasts. Cancer Research 2010; 70(14): 6036 doi: 10.1158/0008-5472.CAN-10-0408
|
| 31 |
Gui‐Bo Wang, Xin‐Yu Zhou, Tao Yuan, Jun Xie, Li‐Ping Guo, Ning Gao, Xiao‐Qin Wang. Significance of Serum Connective Tissue Growth Factor in Patients with Hepatocellular Carcinoma and Relationship with Angiogenesis. World Journal of Surgery 2010; 34(10): 2411 doi: 10.1007/s00268-010-0648-4
|
| 32 |
Cheng-Gang Jiang, Ling Lv, Fu-Rong Liu, Zhen-Ning Wang, Fu-Nan Liu, Yan-Shu Li, Chun-Yu Wang, Hong-Yan Zhang, Zhe Sun, Hui-Mian Xu. Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination. Molecular Cancer 2011; 10(1) doi: 10.1186/1476-4598-10-122
|
| 33 |
Wei-Xin Wang, Qing-Feng Lin, Dong Shen, Shao-Ping Liu, Wei-Dong Mao, Gui Ma, Wei-Dong Qi. Clinicopathological significance of SLP-2 overexpression in human gallbladder cancer. Tumor Biology 2014; 35(1): 419 doi: 10.1007/s13277-013-1058-7
|
| 34 |
Wang Xuqing, Cui Lei, Mao Zhengfa, Dang Shengchun, Fan Xin, Qu Jianguo, Zhang Jianxin. EphB4 is overexpressed in papillary thyroid carcinoma and promotes the migration of papillary thyroid cancer cells. Tumor Biology 2012; 33(5): 1419 doi: 10.1007/s13277-012-0392-5
|
| 35 |
E C Finger, C-F Cheng, T R Williams, E B Rankin, B Bedogni, L Tachiki, S Spong, A J Giaccia, M B Powell. CTGF is a therapeutic target for metastatic melanoma. Oncogene 2014; 33(9): 1093 doi: 10.1038/onc.2013.47
|
| 36 |
Sabin Bhandari, Ingunn Bakke, J. Kumar, Vidar Beisvag, Arne K. Sandvik, Liv Thommesen, Andrea Varro, Kristin G. Nørsett. Connective tissue growth factor is activated by gastrin and involved in gastrin-induced migration and invasion. Biochemical and Biophysical Research Communications 2016; 475(1): 119 doi: 10.1016/j.bbrc.2016.05.052
|
| 37 |
Hanna Drzewiecka, Bartłomiej Gałęcki, Donata Jarmołowska-Jurczyszyn, Andrzej Kluk, Wojciech Dyszkiewicz, Paweł P. Jagodziński. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers. Journal of Cancer Research and Clinical Oncology 2016; 142(9): 1927 doi: 10.1007/s00432-016-2195-3
|
| 38 |
Kyoung-Min Choi, Boram Kim, Su-Min Lee, Jisoo Han, Ha-Song Bae, Su-Bhin Han, Dagyeong Lee, In-Hye Ham, Hoon Hur, Eunjung Kim, Jae-Young Kim. Characterization of gastric cancer-stimulated signaling pathways and function of CTGF in cancer-associated fibroblasts. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01396-7
|
| 39 |
Julia E. Wells, Meegan Howlett, Catherine H. Cole, Ursula R. Kees. Deregulated expression of connective tissue growth factor (CTGF/CCN2)is linked to poor outcome in human cancer. International Journal of Cancer 2015; 137(3): 504 doi: 10.1002/ijc.28972
|
| 40 |
Olav A. Gressner. Less Smad2 is good for you! A scientific update on coffee's liver benefits. Hepatology 2009; 50(3): 970 doi: 10.1002/hep.23097
|
| 41 |
Yangyang Yao, Yi Wang, Li Li, Xiaojun Xiang, Junhe Li, Jun Chen, Zhen Liu, Shanshan Huang, Jianping Xiong, Jun Deng. Down‐regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor. Journal of Cellular and Molecular Medicine 2019; 23(12): 8076 doi: 10.1111/jcmm.14677
|
| 42 |
Feng Zhao, Chan Li, Yun Wu, Jianling Xia, Ming Zeng, Tao Li, Ke Xie, Irene Bottillo. Connective Tissue Growth Factor in Digestive System Cancers: A Review and Meta-Analysis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8489093
|
| 43 |
Olav A. Gressner. About coffee, cappuccino and connective tissue growth factor—Or how to protect your liver!?. Environmental Toxicology and Pharmacology 2009; 28(1): 1 doi: 10.1016/j.etap.2009.02.005
|
| 44 |
Alexander N. Shoushtari, Russell Z. Szmulewitz, Carrie W. Rinker-Schaeffer. Metastasis-suppressor genes in clinical practice: lost in translation?. Nature Reviews Clinical Oncology 2011; 8(6): 333 doi: 10.1038/nrclinonc.2011.65
|